#1 prescribed DMT for MS patients starting or switching to a new therapy 1*

NUMBER OF PATIENTS STARTING OR SWITCHING TO A NEW THERAPY

*From July 2017 to December 2019; Symphony Health, rolling 3-month prescriber-based data; includes both naïve and switch patients. Includes all patients with an ICD-10-CM of G35 (multiple sclerosis).
†From July 2018 to December 2019; Symphony Health, average quarterly prescriber-based data. OCREVUS and the top DMT in each therapy delivery class are illustrated as lines in the chart. The data analyzed include all FDA-approved DMTs for MS as of December 2019.

Over 6 years of patient experience with OCREVUS

Patients prescribed OCREVUS

Adherence & Persistence

See OCREVUS data from clinical trials and a 1-year real-world claims analysis.

Request information

Speak to an OCREVUS Representative to learn more about OCREVUS.

DMT=disease-modifying therapy; PPMS=primary progressive multiple sclerosis; RMS=relapsing multiple sclerosis.